Dr. Balapal Basavarajappa is a leading researcher in neuropsychiatric disorders, investigating the roles of endocannabinoids, synaptic plasticity, and epigenetics in brain function and disease. He serves as a Senior Scientist at the Nathan Kline Institute for Psychiatric Research (Center for Dementia Research, Orangeburg, NY) and a Research Associate Professor at NYU Grossman School of Medicine (Department of Psychiatry, New York, NY). His work bridges molecular mechanisms and behavior, focusing on Fetal Alcohol Spectrum Disorders (FASD), Alcohol Use Disorder (AUD), neurodegeneration, and cognitive deficits, with particular emphasis on gene regulation, learning/memory, and behavioral outcomes. By integrating interdisciplinary approaches, his research aims to identify novel therapeutic targets for brain disorders.
Dr. Balapal Basavarajappa is a leading researcher in neuropsychiatric disorders, investigating the roles of endocannabinoids, synaptic plasticity, and epigenetics in brain function and disease. He serves as a Senior Scientist at the Nathan Kline Institute for Psychiatric Research (Center for Dementia Research, Orangeburg, NY) and a Research Associate Professor at NYU Grossman School of Medicine (Department of Psychiatry, New York, NY). His work bridges molecular mechanisms and behavior, focusing on Fetal Alcohol Spectrum Disorders (FASD), Alcohol Use Disorder (AUD), neurodegeneration, and cognitive deficits, with particular emphasis on gene regulation, learning/memory, and behavioral outcomes. By integrating interdisciplinary approaches, his research aims to identify novel therapeutic targets for brain disorders.